Evidence map›Paper›PMID 39403127›Full record

ArticleFrontiers in cell and developmental biology2024

Targeting caspase-8/c-FLIP

Laura K Hillert-Richter, Corinna König, Nikita V Ivanisenko, Dirk Reinhold, Inna N Lavrik

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Pharmacological Inhibition of cFLIP Targets Breast Cancer Stem Cells.Journal of cancer treatment & diagnosis · 2025
    Article
  3. Review
  4. Pharmacological targeting of caspase-8/c-FLIPCommunications biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura K Hillert-Richter *Translational Inflammation Research, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.
Corinna König *Translational Inflammation Research, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.
Nikita V IvanisenkoTranslational Inflammation Research, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.
Dirk ReinholdInstitute of Molecular and Clinical Immunology, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.
Inna N LavrikTranslational Inflammation Research, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Death receptor (DR) networks are controlled by the assembly of the Death-Inducing Signaling Complex (DISC) and complex II. The family of small molecules FLIPins (FLIP interactors) were developed to target the caspase-8/c-FLIP

Indexed as

caspase-8CD95cell deathc-FLIPcomplex IIFLIPinSMAC mimetic

Identifiers

PMID39403127
PMCPMC11471875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.